NFKB1 and neurodegenerative disease: Given the accumulating evidence that NF-κB pathway activation plays a critical role in the microglia-mediated inflammation that increases oxidative stress and promotes neuronal dysfunctions it is, therefore, imperative to illustrate potential molecular targets against NF-κB pathway activation for the treatments of neurodegenerative diseases.